| 1.52 -0.01 (-0.65%) | 01-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.92 | 1-year : | 2.24 |
| Resists | First : | 1.64 | Second : | 1.92 |
| Pivot price | 1.5  |
|||
| Supports | First : | 1.46 | Second : | 1.36 |
| MAs | MA(5) : | 1.51 |
MA(20) : | 1.48 |
| MA(100) : | 1.61 |
MA(250) : | 1.59 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 59.7 |
D(3) : | 59.1 |
| RSI | RSI(14): 52.7 |
|||
| 52-week | High : | 2.69 | Low : | 0.77 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SKIN ] has closed below upper band by 41.9%. Bollinger Bands are 56.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 29 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.55 - 1.56 | 1.56 - 1.56 |
| Low: | 1.49 - 1.5 | 1.5 - 1.51 |
| Close: | 1.51 - 1.52 | 1.52 - 1.54 |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer's preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Mon, 26 Jan 2026
The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Reduce" from Analysts - MarketBeat
Fri, 23 Jan 2026
Beauty Health (NASDAQ:SKIN) Stock Rating Lowered by Zacks Research - MarketBeat
Wed, 14 Jan 2026
Beauty Health (SKIN): Today's Analyst Rating Update by Jefferies - GuruFocus
Thu, 06 Nov 2025
Here's What Key Metrics Tell Us About Beauty Health (SKIN) Q3 Earnings - Nasdaq
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 128 (M) |
| Shares Float | 83 (M) |
| Held by Insiders | 11.6 (%) |
| Held by Institutions | 89 (%) |
| Shares Short | 16,680 (K) |
| Shares Short P.Month | 17,110 (K) |
| EPS | -0.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.51 |
| Profit Margin | -3.9 % |
| Operating Margin | -8.9 % |
| Return on Assets (ttm) | -3 % |
| Return on Equity (ttm) | -18.8 % |
| Qtrly Rev. Growth | -10.4 % |
| Gross Profit (p.s.) | 1.53 |
| Sales Per Share | 2.36 |
| EBITDA (p.s.) | -0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 39 (M) |
| Levered Free Cash Flow | 38 (M) |
| PE Ratio | -9.5 |
| PEG Ratio | 0 |
| Price to Book value | 2.92 |
| Price to Sales | 0.64 |
| Price to Cash Flow | 5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|